Using the Kaplan–Meier plotter tool (TCGA dataset), we analyzed the impact of TNFRSF1A expression in breast cancer patients and confirmed a significant correlation between lower TNFRSF1A levels and poor prognosis of breast cancer patients (Fig. 1I). This evidence concerns the gene TNFRSF1A and breast carcinoma.